- 血液凝固第IX因子
WordNet
- be a contributing factor; "make things factor into a companys profitability"
- any of the numbers (or symbols) that form a product when multiplied together
- an independent variable in statistics
- anything that contributes causally to a result; "a number of factors determined the outcome"
- consider as relevant when making a decision; "You must factor in the recent developments" (同)factor in, factor out
- resolve into factors; "a quantum computer can factor the number 15" (同)factor in, factor out
- smear with blood, as in a hunting initiation rite, where the face of a person is smeared with the blood of the kill
- temperament or disposition; "a person of hot blood"
- people viewed as members of a group; "we need more young blood in this organization"
- the fluid (red in vertebrates) that is pumped through the body by the heart and contains plasma, blood cells, and platelets; "blood carries oxygen and nutrients to the tissues and carries away waste products"; "the ancients believed that blood was the sea
- an event known to have happened or something known to have existed; "your fears have no basis in fact"; "how much of the story is fact and how much fiction is hard to tell"
- a concept whose truth can be proved; "scientific hypotheses are not facts"
- a piece of information about circumstances that exist or events that have occurred; "first you must collect all the facts of the case"
- a statement or assertion of verified information about something that is the case or has happened; "he supported his argument with an impressive array of facts"
- the 9th letter of the Roman alphabet (同)i
PrepTutorEJDIC
- (…の)『要因』,(…を生み出す)要素《+『in』+『名』(do『ing』)》 / 囲数,約数 / 代理人,《おもに英》仲買人 / =factorize
- 『血』,『血』液 / 流血(bloodshed);殺人 / 気質,気性,血気,血潮 / 『血統』,血縁(kinship);生まれ,家柄;《the~》王家の血統 / (人種・出身国の)系 / 〈人〉‘に'初めての経験をさせる / 〈猟犬〉‘に'初めて獲物を血を味わわせる
- 〈C〉『事実』,実際にある(あった)事 / 〈U〉真相,真実(truth) / 《the~》(法律用語で)犯行
- 『私は』私が
- iodineの化学記号
- 純血の,純種の / 《複合語を作って》「…の血(性質)を持った」の意を表す
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 血漿分画製剤および組換えDNA産生凝固因子 plasma derivatives and recombinant dna produced coagulation factors
- 2. 静脈血栓症の原因の概要 overview of the causes of venous thrombosis
- 3. 止血の概要 overview of hemostasis
- 4. 肝臓の合成能の検査（アルブミン、凝固因子、プロトロンビン時間など） tests of the livers biosynthetic capacity eg albumin coagulation factors prothrombin time
- 5. 後天性の凝固因子阻害物質 acquired inhibitors of coagulation
English Journal
- Nonacog alfa: an analysis of safety data from six prospective clinical studies in different patient populations with haemophilia B treated with different therapeutic modalities.
- Rendo P1, Smith L, Lee HY, Shafer F.
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.Blood Coagul Fibrinolysis.2015 Dec;26(8):912-8. doi: 10.1097/MBC.0000000000000359.
- Nonacog alfa is a recombinant factor IX (FIX) product indicated for treatment and prevention of bleeding episodes in patients with haemophilia B. This posthoc analysis evaluated the safety of nonacog alfa in key clinical studies across 15 years. Data were pooled from six prospective studies that uti
- PMID 26196195
- Maternal low-level somatic mosaicism of Cys155Tyr of F9 in severe hemophilia B.
- Kim HJ1, Lee KO, Yoo KY, Kim SH, Kim HJ.
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.Blood Coagul Fibrinolysis.2015 Dec;26(8):866-8. doi: 10.1097/MBC.0000000000000234.
- Hemophilia B is an X-linked bleeding disorder caused by deficient coagulation factor IX from a mutation in the F9 gene. Here, we report a family with two brothers having severe hemophilia B inherited from a mother with low-level somatic mosaicism of a F9 mutation. The proband was a 2-year-old boy wi
- PMID 25402191
- Rationale for individualizing haemophilia care.
- Sørensen B1, Auerswald G, Benson G, Elezović I, Felder M, Lambert T, Morfini M, Remor E, Salaj P, Santagostino E, Šalek SZ, Ljung R.
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.Blood Coagul Fibrinolysis.2015 Dec;26(8):849-57. doi: 10.1097/MBC.0000000000000225.
- Owing to the heterogeneity in the clinical phenotype of haemophilia A and B, it is now recognized that disease severity (based on factor VIII/IX activity) may no longer be the most appropriate guide for treatment and that a 'one-size-fits-all' approach is unlikely to achieve optimal therapy. Based o
- PMID 25396764
Japanese Journal
- 血液凝固の動的把握と血友病診療の進歩
- 野上 恵嗣
- 日本血栓止血学会誌 25(3), 371-379, 2014
- 要約：血友病は因子活性値が臨床的重症度と極めて相関を示すため，活性が<1 IU/dl は重症，1～5 IU/dl は中等症，> 5～<40 IU/dl は軽症と分類される．しかし，検査上重症度と臨床症状が相関しない症例もしばしばみられる．因子活性と臨床的重症度の乖離には様々な要因が考えられ，凝固一段法による因子活性が生体内全体の止血凝固能を反映するという考えにある程度限界がある． …
- NAID 130004847325
- 低位前方切除を施行した血友病B型併存直腸癌の1例
- 岡 洋右,赤木 由人,衣笠 哲史,白水 和雄
- 日本臨床外科学会雑誌 74(7), 1968-1972, 2013
- … 症例は60歳，男性．約20年前より血友病Bと診断され，膝関節出血等認め，約5年前より第IX因子の補充療法をされていた．血便認め精査にて直腸Ra前壁に約3cm大の2型病変認めた．1-2週に1回の間隔で第IX因子製剤（ノバクトM）1Vを自己注射していたが，手術前日に4V点滴し，低位前方切除術+3郡リンパ節郭清+回腸人工肛門造設術を施行した．術後は3日間2V，その後APTT30-40秒で管理し，延長した時1Vずつ投与 …
- NAID 130004901138
- 血液凝固IX因子―その分子構造と機能発現メカニズムについて―
- 中村 徹,寺澤 秀俊,中冨 靖,濱本 高義
- 日本血栓止血学会誌 24(4), 445-453, 2013
- NAID 130003367370
Related Links
- hemophilia - caused by mutations in the F9 gene Mutations in the F9 gene cause a type of hemophilia called hemophilia B. More than 900 alterations in this gene have been identified. The most common mutations ...
- Factor IX. 20 likes · 0 talking about this. Factor IX is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. It was discovered in 1952 after a young boy ...
Related Pictures
★リンクテーブル★
| リンク元 | 「factor IX complex」「coagulation factor IX」 |
| 関連記事 | 「I」「fact」「factor」「coagulation factor」「blood」 |
「factor IX complex」
- 第IX因子複合体
- 同
- human
「coagulation factor IX」
- 凝固第IX因子
「I」
「fact」
- n.
「factor」
- n.
「coagulation factor」
「blood」